FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Device Total Product Life Cycle Advisory Program Continues

CDRH extends its Total Product Life Cycle Advisory Program to include devices reviewed in the Office of Radiological Health, the Division of Ophthalmi...

latest-news-card-1

Guidance on Addressing Regulated Product Misinformation

FDA publishes a draft question-and-answer guidance to help firms address misinformation about their approved or cleared medical products.

latest-news-card-1
Human Drugs

Guide on Combo Product Risk Analyses

FDA posts a draft guidance entitled Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products, and Combination Products.

latest-news-card-1

Drug Delivery Device Guidance

FDA publishes a draft guidance recommending medical device design outputs essential for establishing and assessing drug delivery performance in device...

Medical Devices

Philips Updates BiPAP Ventilator Use Instructions

FDA says Philips Respironics has updated use instructions for three BiPAP ventilators in a Class 1 recall.

latest-news-card-1

SCOTUS Chevron Decision Harms the Public: Coalition

The Coalition for Sensible Safeguards calls on Congress to enact Chevron deference into law following a Supreme Court decision gutting the 40-year-old...

latest-news-card-1
Medical Devices

Abbott Recalls HeartMate System Monitor

Abbott Medical recalls (Class 1) its HeartMate System Monitor due to atypical behavior of the System Monitor screen.

latest-news-card-1
Human Drugs

Brookfield Medical/Surgical FDA-483

FDA releases the form FDA-483 with four observations from an inspection at the Brookfield, CT-based Brookfield Medical/Surgical Supplies outsourcing f...

latest-news-card-1
Biologics

Complete Response on Rocket Gene Therapy

FDA issues Rocket Pharmaceuticals a complete response letter on its BLA for gene therapy Kresladi (marnetegragene autotemcel; marne-cel) for treating ...

latest-news-card-1
Human Drugs

Shorla Oncology Breast/Ovarian Cancer Drug OKd

FDA approves a Shorla Oncology NDA for Tepylute (thiotepa), a ready-to-dilute formulation for treating breast and ovarian cancer.